HER2-Peptide Vaccination of Patients With Solid Tumors

NCT02276300 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Breast Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Sargramostim
DRUG: HER2-Peptid-Vakzine
DRUG: Imiquimod

Sponsor

Technical University of Munich